{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:28:51Z","timestamp":1759883331798,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.gene.2022.146699","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T13:20:05Z","timestamp":1657113605000},"page":"146699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Frequency of actionable Exomic secondary findings in 160 Colombian patients: Impact in the healthcare system"],"prefix":"10.1016","volume":"838","author":[{"given":"Liliana Elizabeth","family":"Rodr\u00edguez-Salgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Tamar","family":"Silva-Aldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-7202","authenticated-orcid":false,"given":"Esteban","family":"Medina-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Bare\u00f1o-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-0574","authenticated-orcid":false,"given":"Mauricio","family":"Arcos-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Felipe","family":"Silgado-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-0084","authenticated-orcid":false,"given":"Carlos M.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2022.146699_b0005","doi-asserted-by":"crossref","unstructured":"ACMG Board of Directors, 2015. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet. Med. 17, 68-69. https:\/\/doi:10.1038\/gim.2014.151.","DOI":"10.1038\/gim.2014.151"},{"key":"10.1016\/j.gene.2022.146699_b0010","doi-asserted-by":"crossref","unstructured":"The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 2019; 21(7): 1467\u20131468. https:\/\/doi.org\/10.1038\/s41436-019-0502-5.","DOI":"10.1038\/s41436-019-0502-5"},{"issue":"3","key":"10.1016\/j.gene.2022.146699_b0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gr.183483.114","article-title":"Actionable exomic incidental findings in 6503 participants: challenges of variant classification","volume":"25","author":"Amendola","year":"2015","journal-title":"Genome Res."},{"issue":"10","key":"10.1016\/j.gene.2022.146699_b0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jmg.2004.029538","article-title":"Splicing in action: assessing disease causing sequence changes","volume":"42","author":"Baralle","year":"2005","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-018-0174-2","article-title":"Secondary findings in 421 whole exome-sequenced Chinese children","volume":"12","author":"Chen","year":"2018","journal-title":"Hum Genomics."},{"key":"10.1016\/j.gene.2022.146699_b0030","doi-asserted-by":"crossref","unstructured":"Cifuentes, C.L., Rivera-Herrera, A.L., Barreto, G., 2020. BRCA1 and BRCA2 mutations in breast and ovarian cancer families from south west Colombia. Colomb. Med. 163\u2013175. https:\/\/doi.org\/10.25100\/cm.v50i3.2385.","DOI":"10.25100\/cm.v50i3.2385"},{"issue":"3","key":"10.1016\/j.gene.2022.146699_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41431-020-00758-w","article-title":"Opportunistic genomic screening. Recommendations of the European Society of Human Genetics","volume":"29","author":"de Wert","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.gene.2022.146699_b0040","doi-asserted-by":"crossref","unstructured":"Desmet, F.-O., Hamroun, D., Lalande, M., Collod-B\u00e9roud, G., Claustres, M., B\u00e9roud, C., 2009. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37, e67. https:\/\/doi:10.1093\/nar\/gkp215.","DOI":"10.1093\/nar\/gkp215"},{"key":"10.1016\/j.gene.2022.146699_b0045","unstructured":"Dewey, F.E., Murray, M.F., Overton, J.D., Habegger, L., Leader, J.B., Fetterolf, S.N., et al., 2016. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354(6319), aaf6814. https:\/\/doi.org\/ 10.1126\/science.aaf6814."},{"issue":"4","key":"10.1016\/j.gene.2022.146699_b0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajhg.2013.08.006","article-title":"Actionable, pathogenic incidental findings in 1,000 participants\u2019 exomes","volume":"93","author":"Dorschner","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.gene.2022.146699_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physiolgenomics.00025.2021","article-title":"Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review","volume":"53","author":"Elfatih","year":"2021","journal-title":"Physiol. Genomics"},{"issue":"2","key":"10.1016\/j.gene.2022.146699_b0060","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.18632\/oncotarget.12699","article-title":"The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?","volume":"8","author":"Eliade","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.gene.2022.146699_b0065","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.2196\/resprot.4111","article-title":"Cardiovascular Risk and Its Associated Factors in Health Care Workers in Colombia: A Study Protocol","volume":"4","author":"Gamboa Delgado","year":"2015","journal-title":"JMIR Res. Protoc."},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13053-017-0083-8","article-title":"Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory","volume":"16","author":"Gardner","year":"2018","journal-title":"Hered Cancer Clin. Pract."},{"issue":"9","key":"10.1016\/j.gene.2022.146699_b0075","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","author":"Gordon","year":"2020","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.gene.2022.146699_b0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.gene.2022.146699_b0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mgg3.142","article-title":"Novel pathogenic variants and genes for myopathies identified by whole exome sequencing","volume":"3","author":"Hunter","year":"2015","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.gene.2022.146699_b0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00438-018-1431-8","article-title":"Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar","volume":"293","author":"Jain","year":"2018","journal-title":"Mol. Genet. Genomics"},{"key":"10.1016\/j.gene.2022.146699_b0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fgene.2020.00208","article-title":"Actionable Exomic Secondary Findings in 280 Lebanese Participants","volume":"11","author":"Jalkh","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2022.146699_b0100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/gim.2015.26","article-title":"Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes","volume":"17","author":"Jang","year":"2015","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.gene.2022.146699_b0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/gim.2014.196","article-title":"Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics","volume":"17","author":"Jurgens","year":"2015","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.gene.2022.146699_b0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2022.146699_b0115","doi-asserted-by":"crossref","unstructured":"Kalia, S.S., Adelman, K., Bale, S.J., Chung, W.K., Eng, C., Evans, J.P., et al., 2017. CORRIGENDUM: Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 19, 484. https:\/\/doi: 10.1038\/gim.2017.17.","DOI":"10.1038\/gim.2017.17"},{"key":"10.1016\/j.gene.2022.146699_b0120","doi-asserted-by":"crossref","unstructured":"Kwak, S.H., Chae, J., Choi, S., Kim, M.J., Choi, M., Chae, J.-H., et al., 2017. Findings of a 1303 Korean whole-exome sequencing study. Exp. Mol. Med. 49, e356. https:\/\/doi:10.1038\/emm.2017.142.","DOI":"10.1038\/emm.2017.142"},{"issue":"D1","key":"10.1016\/j.gene.2022.146699_b0125","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.gene.2022.146699_b0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/gim.2014.29","article-title":"The implications of familial incidental findings from exome sequencing: the NIH undiagnosed diseases program experience","volume":"16","author":"Lawrence","year":"2014","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.gene.2022.146699_b0135","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/bjc.2014.30","article-title":"Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease","volume":"110","author":"Leongamornlert","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.gene.2022.146699_b0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.30944\/20117582.38","article-title":"C\u00e1ncer colorrectal hereditario no asociado a poliposis o s\u00edndrome de Lynch","volume":"32","author":"Mart\u00ednez","year":"2017","journal-title":"Revista Colombiana de Cirug\u00eda."},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-017-2840-1","article-title":"A first description of the Colombian national registry for rare diseases","volume":"10","author":"Mateus","year":"2017","journal-title":"BMC Res. Notes"},{"issue":"8","key":"10.1016\/j.gene.2022.146699_b0150","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.gene.2022.146699_b0155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41436-021-01278-8","article-title":"Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.gene.2022.146699_b0160","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0379-0738(03)00271-8","article-title":"Analysis of the CODIS autosomal STR loci in four main Colombian regions","volume":"137","author":"Paredes","year":"2003","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.gene.2022.146699_b0170","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.gene.2022.146699_b0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.gene.2022.146699_b0180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/gim.2017.254","article-title":"MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer","volume":"20","author":"Roberts","year":"2018","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.gene.2022.146699_b0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-016-1656-8","article-title":"Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy","volume":"133","author":"Schartner","year":"2017","journal-title":"Acta Neuropathol. abril de"},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/gim.2014.165","article-title":"Reporting genomic secondary findings: ACMG members weigh in","volume":"17","author":"Scheuner","year":"2015","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.gene.2022.146699_b0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajhg.2018.07.009","article-title":"A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort","volume":"103","author":"Schwartz","year":"2018","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.gene.2022.146699_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00439-017-1852-1","article-title":"Actionable secondary findings from whole-genome sequencing of 954 East Asians","volume":"137","author":"Tang","year":"2018","journal-title":"Hum. Genet."},{"issue":"29","key":"10.1016\/j.gene.2022.146699_b0205","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer Risks for PMS2 -Associated Lynch Syndrome","volume":"36","author":"ten Broeke","year":"2018","journal-title":"JCO."},{"issue":"7831","key":"10.1016\/j.gene.2022.146699_b0210","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gene.2022.146699_b0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s10038-017-0347-1","article-title":"Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals","volume":"63","author":"Yamaguchi-Kabata","year":"2018","journal-title":"J. Hum. Genet."},{"issue":"18","key":"10.1016\/j.gene.2022.146699_b0220","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2022.146699_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajhg.2014.06.004","article-title":"Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing","volume":"95","author":"Yu","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2022.146699_b0230","doi-asserted-by":"crossref","unstructured":"Zhong, X., Guo, W., Wei, J., Tang, Y., Liu, Y., Zhang, J.Z., et al., 2021. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death. Biosci. Rep. 41(4), BSR20210209. https:\/\/doi.org\/10.1042\/BSR20210209.","DOI":"10.1042\/BSR20210209"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922005182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922005182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:55:25Z","timestamp":1759856125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111922005182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S0378111922005182"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2022.146699","relation":{},"ISSN":["0378-1119"],"issn-type":[{"type":"print","value":"0378-1119"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of actionable Exomic secondary findings in 160 Colombian patients: Impact in the healthcare system","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2022.146699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146699"}}